SLANSKY RICHARD B 4
Research Summary
AI-generated summary
Genenta (GNTA) CFO Richard Slansky Receives 80,000-Share Award
What Happened Richard B. Slansky, Chief Financial Officer of Genenta Science S.p.A. (GNTA), was granted a derivative award covering 80,000 shares on March 30, 2026. The grant is reported as acquired at $0.00 (total reported cash paid = $0). This is an equity award (stock options per filing footnote) rather than a market purchase or sale.
Key Details
- Transaction date: 2026-03-30; reported on Form 4 filed 2026-04-01 (appears timely).
- Transaction type: Grant / award of a derivative (stock options) — 80,000 shares @ $0.00.
- Shares owned after transaction: Not disclosed in the filing.
- Footnote: F1 — the options vest in equal monthly installments over three years beginning March 30, 2026.
- No indication of immediate sale or tax-withholding reported in this filing.
Context This is a standard executive equity grant intended to align management incentives with shareholders; it does not represent an open-market purchase or sale. For retail investors, grants signal compensation/retention actions by the company but do not by themselves indicate the insider’s view on short-term stock moves.